drugset / Trial / NCT05728671

Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015

NCT05728671

Phase 1 Unknown 12 enrolled Initiator Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

The study's primary objective is to determine the bioavailability of two solid formulations of IP2015 compared to a liquid formulation of IP2015 in healthy male subjects

Timeline

Start
2023-02-16
Primary completion
2023-05-16
Completion
2023-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Pudafensine Small molecule

Indications

No indication recorded.